Umbilical cord blood lacks circulating B lymphocytes expressing surface IgG or IgA

Clinical Immunology and Immunopathology

Volumn 84, Issue 3, 1997, Pages 276-282

  Wedgwood, Josiah F ^a,b   Weinberger, Barry I ^a   Hatam, Lynda ^b,c   Palmer, Richard ^a  

^a Division of Newborn Medicine   (United States)

^b SCHNEIDER CHILDREN'S HOSPITAL   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MESSENGER RNA;

ARTICLE; B LYMPHOCYTE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MONONUCLEAR CELL; NEWBORN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

EID: 0031240005     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4402     Document Type: Article

References (33)

1. Andersson U., Bird A. G., Britton S., Palacios R. Humoral and cellular immunity in humans studied at the cell level from birth to two years of age. Immunol. Rev. 57:1981;5-38.
2. Gathings W. E., Kubagawa H., Cooper M. D. A distinctive pattern of B cell immaturity in perinatal humans. Immunol. Rev. 57:1981;107-126.
3. Hayward A. R. Development of lymphocyte responses and interactions in the human fetus and newborn. Immunol. Rev. 57:1981;39-60.
4. Miyawaki T., Moriya N., Nagaoki T., Taniguchi N. Maturation of B-cell differentiation ability and T-cell regulatory function in infancy and childhood. Immunol. Rev. 57:1981;61-87.
5. Mayumi M., Kuritani T., Kubagawa H., Cooper M. D. IgG subclass expression by human B lymphocytes and plasma cells: B lymphocytes precommitted to IgG subclass can be preferentially induced by polyclonal mitogens with T cell help. J. Immunol. 130:1983;671-677.
6. Andersson U. Development of B lymphocyte function in childhood. Acta Paediatr. Scand. 74:1985;568-573.
7. Andersson U., Bird G., Britton S. Cellular mechanisms of restricted immunoglobulin formation in the human neonate. Eur. J. Immunol. 10:1980;888-894.
8. Miyawaki T., Kubagawa H., Butler J. L., Cooper M. D. Ig isotypes produced by EBV-transformed B cells as a function of age and tissue distribution. J. Immunol. 140:1988;3887-3892.
9. Gathings W. E., Lawton A. R., Cooper M. D. Immunofluorescent studies of the development of pre-B cells, B lymphocytes and immunoglobulin isotype diversity in humans. Eur. J. Immunol. 7:1977;804-810.
10. Dosch H-M., Lam P., Hui M. F., Hibi T. Concerted generation of Ig isotype diversity in human fetal bone marrow. J. Immunol. 143:1989;2464-2469.
11. Durandy A., Thuillier L., Forveille M., Fischer A. Phenotypic and functional characteristics of human newborn B lymphocytes. J. Immunol. 144:1990;60-65.
12. Hayward A. R., Lawton A. R. Induction of plasma cell differentiation of human fetal lymphocytes: Evidence for functional immaturity of T and B cells. J. Immunol. 119:1977;1213-1217.
13. Yachie A., Miyawaki T., Nagaoki T., Yokoi T., Mukai M., Uwadana N., Taniguchi N. Regulation of B cell differentiation by T cell subsets defined with monoclonal OKT4 and OKT8 antibodies in human cord blood. J. Immunol. 127:1981;1314-1317.
14. Sideras P., Mizuta T. R., Kanamori H., Suski N., Okamoto M., Kuze K., Ohno H., Doi S., Fukuhara S., Hassan M. S., Hammarström L., Smith E., Schimizu A., Honjo T. Production of sterile transcripts of Cγ genes in an IgM producing human neoplastic B cell line that switches to IgG producing cells. Int. Immunol. 1:1989;631-642.
15. Boyum A. Separation of blood leucocytes, granulocytes and lymphocytes. Tissue Antigens. 4:1974;269-274.
16. Thiele D. L., Kurosaka M., Lipsky P. E. Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: Delineation by its sensitivity to the lysosomotropic agent, l-leucine methyl ester. J. Immunol. 131:1983;2282-2290.
17. Kumagai K., Abo T., Sekizawa T., Sasaki M. Studies of surface immunoglobulins on human B lymphocytes. I. Dissociation of cell-bound immunoglobulins with acid pH or at 37°C. J. Immunol. 115:1975;982-987.
18. Siegal F. P. IgG on infants' B lymphocytes: Enhanced binding of IgG by IgM-bearing lymphoid cells in early childhood. Scand. J. Immunol. 5:1976;721-729.
19. Splawski J. R., Lipsky P. E. Cytokine regulation of immunoglobulin secretion by neonatal lymphocytes. J. Clin. Invest. 88:1991;967-977.
20. Tucci A., Mouzaki A., James H., Bonnefy J-Y., Zubler R. H. Are cord blood B cells functionally mature? Clin. Exp. Immunol. 84:1991;389-394.
21. Punnonen J., Aversa G. G., Vandekerckhove B., Roncarolo M.-G., De Vries J. E. Induction of isotype switching and Ig production by CD5+ and CD10+ human fetal B cells. J. Immunol. 148:1992;3398-3404.
22. Brugnoni D., Airo P., Graf D., Marconi M., Lebowitz M., Plebani A., Giliani S., Malacarne F., Cattaneo R., Ugazio A. G., Albertini A., Kroczek R. A., Notarangelo L. D. Ineffective expression of CD40 ligand on cord blood T cells may contribute to poor immunoglobulin production in the newborn. Eur. J. Immunol. 24:1994;1919-1924.
23. Fuleihan R., Ahern D., Geha R. S. Decreased expression of the ligand for CD40 in newborn lymphocytes. Eur. J. Immunol. 24:1994;1925-1928.
24. Durandy A., De Saint Basile G., Lisowska-Grospierre B., Gauchat J. F., Forveille M., Kroczek R. A., Bonnefoy J. Y., Fischer A. Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns. J. Immunol. 154:1995;1560-1568.
25. Nonoyama S., Penix L. A., Edwards C. P., Lewis D. B., Ito S., Aruffo A., Wilson C. B., Ochs H. D. Diminished expression of CD40 ligand by activated neonatal T cells. J. Clin. Invest. 95:1995;66-75.
26. Aruffo A., Farrington M., Hollenbaugh D., Li X., Milatovich A., Nonoyama S., Bajorath J., Grosmaire L. S., Stenkamp R., Neubauer M., Roberts R. L., Noelle R. J., Ledbetter J. A., Francke U., Ochs H. D. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 72:1993;291-300.
27. Korthauer U., Graf D., Mages H. W., Briere F., Padayachee M., Malcolm S., Ugazio A. G., Notarangelo L. D., Levinsky R. J., Kroczek R. A. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature. 361:1993;539-541.
28. DiSanto J. P., Bonnefoy J. Y., Gauchat J. F., Fischer A., de Saint Basile G. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature. 361:1993;541-543.
29. Allen R. C., Armitage R. J., Conley M. E., Rosenblatt H., Jenkins N. A., Copeland N. G., Bedell M. A., Edelhoff S., Disteche C. M., Simoneaux D. K., Fanslow W. C., Belmont J., Springgs M. K. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science. 259:1993;990-993.
30. Fuleihan R., Ramesh N., Loh R., Jabara H., Rosen R. S., Chatila T., Fu S. M., Stamenkovic I., Geha R. S. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc. Natl. Acad. Sci. USA. 90:1993;2170-2173.
31. Splawski J. B., Nishioka J., Nishioka Y., Lipsky P. E. CD40 ligand is expressed and functional on activated neonatal T cells. J. Immunol. 156:1996;119-127.
32. Bos N. A., Meeuwsen C. G., Wostmann B. S., Pleasants J. R., Benner R. The influence of exogenous antigenic stimulation on the specificity repertoire of background immunoglobulin-secreting cells of different isotypes. Cell Immunol. 112:1988;371-380.
33. Sarvas H., Seppala I., Kurikka S., Siegberg R., Makela O. Half-life of the maternal IgG1 allotype in infants. J. Clin. Immunol. 13:1993;145-151.